object
carbapenemresist
acinetobact
calcoaceticusacinetobact
baumannii
complex
cra
complex
infect
one
difficult
infect
control
worldwid
evalu
longterm
effect
infect
control
intervent
incid
densiti
healthcareassoci
infect
hai
cra
complex
infect
rate
acinetobact
calcoaceticusacinetobact
baumannii
complex
bacteremia
ab
patient
method
perform
crosssect
analysi
changhua
period
infect
control
program
improv
inservic
educ
hand
hygien
campaign
prepar
intern
nation
hospit
accredit
effect
infect
antibiot
control
program
assess
accord
incid
densiti
hai
cra
complex
rate
cra
complex
ab
chlorhexidin
consumpt
densiti
defin
daili
dose
antibiot
result
incid
densiti
hai
decreas
period
p
likewis
incid
ab
decreas
per
personyear
per
admiss
p
incid
densiti
cra
complex
rang
chlorhexidin
consumpt
densiti
increas
l
per
patientday
p
consumpt
piperacillintazobactam
lower
period
period
p
conclus
educ
infect
control
program
hand
hygien
campaign
antibiot
control
program
may
decreas
incid
densiti
ab
hai
may
help
control
cra
complex
infect
objectif
linfect
aux
acinetobact
calcoaceticusacinetobact
baumannii
complex
cra
complex
est
lune
de
infect
le
plu
difficil
dan
le
mond
entier
cett
le
effet
long
term
de
intervent
de
lutt
contr
le
infect
sur
le
dincid
de
linfect
nosocomial
hai
et
de
linfect
cra
complex
ainsi
que
le
taux
de
cra
complex
patient
acinetobact
calcoaceticusacinetobact
baumannii
complex
acb
complex
emerg
import
healthcareassoci
pathogen
surviv
wide
rang
environment
condit
persist
extens
use
medic
devic
modern
medic
institut
contribut
emerg
acb
complex
predomin
pathogen
infect
caus
multidrugresist
acb
complex
mdracb
complex
current
consid
difficult
infect
control
sever
predispos
factor
colon
infect
acb
complex
speci
widespread
environment
contamin
frequent
report
acb
complex
infect
increas
worldwid
mdracb
complex
isol
taiwan
sinc
taiwan
acb
complex
predomin
pathogen
caus
bloodstream
infect
associ
high
risk
antibiot
resist
furthermor
patient
mdracb
complex
bacteremia
higher
mortal
rate
patient
nonmdracb
complex
bacteremia
overal
mortal
mdracb
complex
bloodstream
infect
rang
previous
demonstr
mdracb
complex
could
occur
result
crossinfect
natur
mutat
crossinfect
avoid
increas
precaut
contact
clinic
practic
wherea
natur
mutat
prevent
deescal
broadspectrum
antibiot
howev
optim
treatment
strategi
unknown
sever
author
report
variabl
degre
success
control
mdracb
complex
use
intervent
promot
hand
hygien
isol
contact
precaut
environment
clean
target
activ
surveil
temporari
unit
closur
antibiot
control
program
data
taiwan
nosocomi
infect
surveil
system
tni
reveal
recent
overal
decreas
hospitalassoci
infect
hai
intens
care
unit
icu
acut
care
hospit
medic
center
per
patientday
per
patientday
region
hospit
per
patientday
per
patientday
although
overal
rate
hai
decreas
proport
hai
caus
carbapenemresist
calcoaceticusa
baumannii
complex
cra
complex
greater
caus
acb
complex
particular
cra
complex
increas
icu
medic
center
region
hospit
changhua
christian
hospit
cch
receiv
onsit
survey
hospit
accredit
healthcarerel
infect
control
audit
qualiti
improv
taiwan
joint
commiss
hospit
accredit
tjcha
annual
patient
safeti
goal
includ
infect
controlhand
hygien
tube
safeti
cch
also
receiv
onsit
survey
hospit
accredit
joint
commiss
intern
jcia
includ
prevent
control
infect
core
standard
accordingli
cch
organ
campaign
hand
hygien
champion
antibiot
control
program
although
control
transmiss
cra
complex
high
prioriti
tertiari
care
hospit
littl
inform
cra
complex
control
taiwan
therefor
evalu
longterm
effect
infect
antibiot
control
program
incid
cra
complex
calcoaceticusa
baumannii
complex
bacteremia
ab
changhua
christian
healthcar
system
charg
changhua
popul
taiwan
maintain
comprehens
clinic
record
sinc
changhua
counti
locat
central
taiwan
popul
cch
member
cch
system
tertiari
referr
medic
center
locat
northern
changhua
counti
cch
jciaccredit
hospit
sinc
studi
consist
baselin
period
januari
decemb
period
campaign
intervent
period
januari
decemb
period
campaign
intervent
team
includ
hospit
administr
infecti
diseas
physician
infect
control
nurs
hospit
epidemiologist
clinic
microbiologist
clinic
pharmacist
case
ab
identifi
microbiolog
databas
medic
record
accord
intern
classif
diseas
ninth
edit
clinic
modif
cch
central
taiwan
use
computer
indic
find
case
follow
code
case
acb
complex
isol
blood
select
review
patient
medic
record
contain
medic
diagnos
surgic
intervent
key
inform
medic
record
medic
record
ab
case
review
primari
investig
cch
confirm
diagnosi
use
cch
system
resourc
case
judg
problemat
review
secondari
investig
cyj
first
episod
ab
patient
studi
period
includ
statist
analysi
diseas
incid
calcul
consid
entir
admit
patient
popul
cch
risk
infect
acb
complex
isol
cultur
blood
consid
clinic
signific
ab
defin
isol
acb
complex
patient
januari
decemb
exclus
criteria
incomplet
data
inconsist
data
code
microbiolog
dataset
ab
classifi
healthcareonset
communityacquir
accord
modifi
version
horan
definit
healthcareonset
infect
defin
posit
blood
cultur
obtain
patient
time
hospit
admiss
within
hour
admiss
patient
fulfil
follow
criteria
receiv
intraven
therapi
home
receiv
wound
care
special
nurs
care
healthcar
agenc
famili
friend
selfadminist
intraven
medic
therapi
within
day
ab
infect
patient
exclus
use
oxygen
home
therapi
also
exclud
attend
hospit
hemodialysi
clinic
receiv
intraven
chemotherapi
invas
procedur
within
day
ab
infect
hospit
acutecar
hospit
day
period
ab
infect
resid
nurs
home
longterm
care
facil
communityonset
infect
defin
posit
blood
cultur
obtain
time
hospit
admiss
within
hour
hospit
admiss
patient
meet
criteria
healthcareonset
infect
sever
diagnost
system
microbiolog
cultur
use
microbiolog
databas
cch
studi
period
includ
api
api
labalm
le
grott
franc
autom
system
autom
system
use
sinc
two
set
blood
cultur
routin
perform
analyz
use
vitek
gni
card
hazelwood
mo
usa
system
cch
laboratori
certifi
colleg
american
pathologist
sinc
cra
complex
isol
defin
imipenem
meropenem
mic
mgl
accord
guidelin
clinic
laboratori
standard
institut
ab
isol
meet
definit
cra
complex
consid
suscept
acb
complex
perform
smallscal
valid
studi
casefind
procedur
test
valid
system
review
complet
medic
chart
patient
relev
code
obtain
record
microbiolog
dataset
decemb
end
studi
period
examin
reliabl
casefind
procedur
randomli
select
record
potenti
case
review
independ
infectiousdiseas
specialist
cch
cyj
final
increas
reliabl
diagnos
infectiousdiseas
specialist
assess
cch
case
judg
problemat
panel
accept
diagnos
case
examin
reject
hand
hygien
champion
antibiot
control
program
promot
sinc
campaign
hand
hygien
champion
antibiot
control
program
includ
contact
isol
cohort
environment
clean
meet
addit
strategi
hand
hygien
champion
strategi
antibiot
control
program
infect
prevent
measur
campaign
list
appendix
chronolog
data
healthcareassoci
infect
catheterassoci
urinari
tract
infect
central
lineassoci
bloodstream
infect
ventilatorassoci
pneumonia
cch
list
appendix
infect
control
nurs
directli
observ
cleaner
habit
throughout
studi
includ
weekend
night
shift
note
whether
environment
site
clean
record
result
everi
week
percentag
properli
clean
item
calcul
infect
control
nurs
hand
hygien
offic
also
monitor
adher
hand
hygien
gown
glove
unit
variou
time
day
studi
hand
hygien
observ
began
healthcar
worker
enter
intervent
unit
observ
perform
activ
involv
contact
patient
environ
end
healthcar
worker
complet
activ
infect
control
nurs
hand
hygien
offic
perform
daili
round
enforc
use
daili
chlorhexidin
bath
addit
pharmaci
depart
provid
regular
report
chlorhexidin
use
mention
observ
made
infect
control
nurs
hand
hygien
offic
throughout
studi
observ
randomli
perform
twice
per
week
requir
least
observ
opportun
per
month
period
descript
statist
spss
version
window
spss
inc
chicago
il
usa
calcul
analyz
case
characterist
laboratori
paramet
group
demograph
data
clinic
characterist
compar
use
test
student
ttest
appropri
test
pvalu
consid
statist
signific
patient
admit
cch
studi
period
includ
adult
patient
present
least
episod
ab
sixtyfour
patient
exclud
conflict
code
data
microbiolog
dataset
incomplet
data
final
patient
includ
appendix
summari
chronolog
data
patient
ab
cch
chronolog
data
acb
complex
isol
includ
cra
complex
densiti
healthcareassoci
infect
cch
taiwan
nosocomi
infect
surveil
list
appendix
incid
ab
cch
per
patientyear
cumul
number
admiss
lower
outbreak
sever
acut
respiratori
syndrom
sar
taiwan
respect
use
cephalosporin
p
penicillin
p
carbapenem
antibiot
p
ab
episod
gradual
increas
throughout
studi
period
thirdand
fourthgener
cephalosporin
antibiot
eg
cefepim
piperacillintazobactam
imipenemcilastatin
meropenem
use
frequent
two
hundr
twentyfour
patient
die
studi
period
crude
mortal
rate
incid
ab
adult
patient
consult
cch
increas
per
patientyear
per
patientyear
appendix
incid
densiti
hai
decreas
per
patientday
per
patientday
p
cra
complex
bacteremia
show
signific
increas
linear
trend
calendar
year
throughout
studi
period
p
furthermor
distribut
trend
type
sourc
infect
differ
significantli
calendar
year
throughout
studi
period
p
number
patient
previous
treat
antibiot
ab
episod
decreas
slightli
distribut
antibiot
type
includ
cephalosporin
penicillin
carbapenem
aminoglycosid
show
signific
increas
linear
trend
calendar
year
throughout
studi
period
p
crude
mortal
rate
ab
mortal
rate
rang
studi
period
signific
increas
linear
trend
mortal
calendar
year
throughout
studi
period
p
eight
hundr
nineti
patient
admit
studi
period
period
respect
signific
differ
patient
demograph
clinic
characterist
period
tabl
total
acb
complex
isol
episod
ab
identifi
period
number
annual
isol
acb
complex
episod
ab
annual
isol
cra
complex
lower
period
period
p
reduct
incid
densiti
hai
reduct
incid
ab
period
compar
period
signific
differ
number
acb
complex
isol
period
incid
patient
ab
period
per
personyear
per
admiss
respect
p
tabl
rate
cra
complex
increas
period
decreas
period
p
incid
densiti
cra
complex
rang
studi
period
fig
although
differ
incid
central
lineassoci
bloodstream
infect
ventil
associ
pneumonia
catheterassoci
urinari
tract
infect
period
incid
cra
complex
decreas
significantli
appendix
healthcar
worker
adher
infect
prevent
measur
differ
period
tabl
twenti
healthcar
worker
present
skin
reaction
chlorhexidin
period
reaction
diffus
maculopapular
rash
confirm
dermatologist
fifthteen
healthcar
worker
present
advers
skin
reaction
chlorhexidin
diagnos
underli
dermat
histori
skin
allergi
bodi
lotion
patient
present
sever
anaphylaxi
pattern
antibiot
prescript
differ
studi
new
antibiot
control
program
howev
antibiot
consumpt
significantli
correl
decreas
incid
densiti
cra
complex
p
consumpt
antibiot
differ
period
tabl
consumpt
piperacillintazobactam
significantli
lower
period
period
p
analyz
longterm
effect
campaign
infect
control
program
includ
hand
hygien
champion
antibiot
control
program
control
cra
complex
infect
period
accord
intern
accredit
program
ie
jcia
nation
accredit
program
ie
hospit
accredit
healthcarerel
infect
control
audit
qualiti
improv
tjcha
accredit
program
improv
manag
provid
healthcar
servic
furthermor
studi
provid
addit
evid
improv
infect
control
prevent
use
measur
incid
ab
increas
wilk
et
al
describ
method
control
outbreak
multidrugresist
baumanniicalcoaceticu
colon
infect
icu
without
close
icu
place
patient
isol
et
al
report
use
comprehens
care
program
control
endem
multidrugresist
baumannii
tni
data
demonstr
recent
overal
decreas
hai
icu
acut
care
hospit
although
overal
rate
hai
decreas
hai
caus
cra
complex
acb
complex
particular
rate
cra
complex
compar
rate
acb
complex
icu
medic
center
increas
region
hospit
incid
ab
cch
central
taiwan
increas
accord
studi
highlight
critic
need
infect
control
prevent
measur
result
concern
effect
infect
control
intervent
mix
impact
hospit
accredit
infect
control
remain
determin
find
studi
suggest
educ
intervent
hospit
accredit
process
influenc
adher
infect
control
measur
especi
hand
hygien
data
corrobor
survey
japanes
hospit
author
identifi
signific
associ
infect
control
perform
score
hospit
accredit
statu
regardless
hand
hygien
complianc
assum
cohort
patient
cra
complex
infect
studi
still
significantli
reduc
spread
cra
complex
use
cohort
room
isol
cra
complex
patient
monitor
incid
densiti
hai
rate
methicillinresist
staphylococcu
aureu
serv
control
paramet
episod
ab
serv
observ
paramet
evalu
impact
isol
precaut
infect
control
measur
similar
studi
cheng
et
al
incid
densiti
hai
decreas
increas
chlorhexidin
consumpt
densiti
follow
educ
hand
hygien
promot
period
wherea
cra
complex
unabl
determin
proport
reduc
cra
complex
incid
densiti
attribut
decreas
patienttopati
transmiss
cohort
like
improv
complianc
infect
control
measur
includ
hand
hygien
corrobor
previou
author
demonstr
effect
isol
precaut
patient
cra
complex
infect
colon
despit
lack
specif
antibiot
control
measur
studi
period
consumpt
antibiot
carbapenem
decreas
period
although
unabl
evalu
causal
relationship
antibiot
consumpt
incid
densiti
cra
complex
find
suggest
reduct
cra
complex
incid
densiti
could
relat
level
antibiot
consumpt
consist
previou
report
difficult
determin
causal
effect
underli
decreas
incid
densiti
hai
rate
cra
complex
particularli
respect
rate
antibiot
resist
attribut
antibiot
use
rate
patienttopati
transmiss
studi
first
crosssect
analysi
ab
central
taiwan
previous
studi
chang
clinic
featur
ab
changhua
counti
taiwan
appendix
incid
ab
adult
cch
increas
per
patientyear
per
patientyear
incid
ab
increas
steadili
decreas
appendix
signific
increas
linear
trend
cra
complex
bacteremia
studi
although
incid
ab
lower
taiwan
saudi
arabia
difficult
compar
incid
observ
studi
countri
differ
method
use
studi
result
show
incid
cra
complex
bacteremia
increas
significantli
cch
sinc
cra
complex
bacteremia
increas
studi
period
mainli
increas
cra
complex
isol
increas
healthcareassoci
ab
communityacquir
cra
complex
bacteremia
result
correl
kuo
et
al
antibiot
use
onset
infect
chang
studi
period
increas
cra
complex
infect
antibiot
use
chang
significantli
studi
period
explain
increas
incid
cra
complex
well
increas
complex
sever
underli
diseas
crude
mortal
rate
signific
increas
mortal
studi
period
number
patient
present
cra
complex
bacteremia
increas
crude
mortal
rate
remain
studi
period
explain
part
rel
low
virul
cra
complex
improv
support
care
jang
et
al
observ
signific
differ
cumul
surviv
curv
patient
present
ab
control
patient
likewis
jamulitrat
et
al
observ
signific
differ
mortal
rate
among
patient
imipenemresist
imipenemsuscept
acb
complex
group
result
consist
also
analyz
variabl
contribut
decreas
incid
densiti
hai
rate
cra
complex
incid
ab
studi
period
appendix
inservic
educ
infect
control
program
promot
hand
hygien
enhanc
antibiot
control
program
prepar
hospit
accredit
appear
effect
control
cra
complex
infect
ab
episod
cch
howev
isol
precaut
cra
complex
allow
control
cra
complex
infect
period
poor
complianc
complianc
infect
control
intervent
critic
requisit
affect
control
cra
complex
infect
perform
activ
screen
cultur
would
allow
earli
detect
patient
cra
complex
hospit
admiss
hospit
consequ
prompt
contact
precaut
reduc
persontoperson
transmiss
optim
surveil
sampl
method
mdracb
complex
contrari
multidrugresist
pathogen
author
previou
studi
report
low
mdracb
complex
surveil
cultur
sensit
mdracb
complex
detect
sampl
expens
increas
workload
healthcar
worker
consequ
implement
activ
microbiolog
screen
could
inappropri
detect
cra
complex
carrier
furthermor
author
even
report
benefit
perform
activ
surveil
cultur
cra
complex
furthermor
complianc
infect
control
intervent
studi
might
suboptim
period
intern
extern
audit
reveal
signific
decreas
incid
densiti
hai
period
assum
hand
hygien
campaign
launch
hospit
accredit
program
period
greatli
enhanc
complianc
led
increas
chlorhexidin
consumpt
densiti
studi
sever
strong
point
importantli
accumul
complet
longitudin
dataset
year
access
excel
data
evalu
demograph
featur
ab
implement
campaign
hand
hygien
champion
complianc
jcia
tjcha
antibiot
stewardship
control
cra
complex
infect
thu
abl
provid
detail
inform
infect
control
intervent
find
provid
invalu
epidemiolog
inform
ab
cra
complex
central
taiwan
nevertheless
studi
sever
limit
individu
effect
intervent
evalu
sever
action
introduc
simultan
sequenti
accord
requisit
jcia
tjcha
moreov
complianc
variou
intervent
studi
period
could
check
part
studi
perform
retrospect
calcul
incid
ab
cch
like
underestim
case
ab
infect
exclud
furthermor
case
ab
infect
blood
cultur
treat
broadspectrum
antibiot
blood
cultur
might
overlook
howev
case
like
account
larg
rate
ab
case
data
antibiot
histori
inaccur
mani
patient
receiv
antibiot
month
ab
infect
episod
includ
patient
communityand
healthcareonset
infect
part
studi
perform
retrospect
defin
daili
dose
variou
antibiot
administ
studi
period
could
calcul
antibiot
alter
lack
avail
manpow
furthermor
perform
pulsedfield
gel
electrophoresi
type
cra
complex
isol
evid
outbreak
studi
period
thu
role
patienttopati
transmiss
acquisit
cra
complex
could
document
studi
result
suggest
adher
infect
stewardship
mean
inservic
educ
hand
hygien
campaign
antibiot
control
program
import
decreas
incid
densiti
ab
hai
may
help
control
cra
complex
infect
author
contribut
changhua
chen
chuneng
liu
mawsoan
soon
design
research
collect
data
draft
articl
analyz
data
interpret
result
lichen
lin
analyz
microbiolog
process
yujun
chang
analyz
statist
data
author
read
approv
final
version
articl
author
declar
conflict
interest
concern
articl
